Introduzca una acción o criptomoneda en el cuadro de búsqueda para obtener un resumen
Thyrocare Technologies Limited
THYROCAREThyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, and various infectious diseases. Its profiles of tests include profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The company sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radiopharmaceutical products. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited. Address: D/37-3, TTC Industrial Area, Navi Mumbai, India, 400703
Analytics
Precio Objetivo de WallStreet
65 923.47 INRRelación P/E
58.7152Rentabilidad por dividendo
1.93 %Año en curso
Año anterior
Trimestre actual
Último trimestre
Año en curso
Año anterior
Trimestre actual
Último trimestre
Cifras clave THYROCARE
Análisis de dividendos THYROCARE
Aumento del dividendo durante 5 años
80 %Crecimiento continuo
1 AñoRatio de pago medio en 5 años
96 %Tendencia del payout THYROCARE
Valoración de la acción THYROCARE
Finanzas THYROCARE
Realice un seguimiento de las métricas clave de cada acción en un solo lugar y sin complicaciones
Hazte premiumResultados | 2019 | Dinámica |